Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide genetic overlap between fear-based disorders and generalised anxiety disorder.

Molecular psychiatry·2026
Same author

Reduced Prevalence of Impaired Awareness of Hypoglycemia Over Two Decades in Population-Based Samples of Youth With Type 1 Diabetes.

Diabetes care·2026
Same author

Diabetic Retinopathy Outcomes and Early Worsening of Diabetic Retinopathy in Adolescents and Young Adults With Type 1 Diabetes Following Rapid and Large Glycemic Improvements After Commencing Automated Insulin Delivery.

Journal of diabetes science and technology·2026
Same author

Health Service Leaders' Perspectives on Type 1 Diabetes Models of Care for Children and Young Adults in Australia: A Mixed-Methods Study.

Journal of diabetes research·2026
Same author

Predicting mortality with machine learning & biomarkers: A cohort analysis from aerosolized β₂-agonist for treatment of acute lung injury (ALTA) trial.

Physiological reports·2026
Same author

Computational Modelling Reveals Slower Safety Learning and Threat Extinction are Associated With Higher Anxiety Severity in Remote Fear Conditioning.

Computational psychiatry (Cambridge, Mass.)·2026

Related Experiment Video

Updated: Jun 16, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Hypoglycemia alarm enhancement using data fusion.

Victor N Skladnev1, Stanislav Tarnavskii, Thomas McGregor

  • 1AiMedics Pty. Ltd., Eveleigh, New South Wales, Australia. skladnev@aimedics.com

Journal of Diabetes Science and Technology
|February 20, 2010
PubMed
Summary

Integrating autonomic nervous system (ANS) features with continuous glucose monitoring systems (CGMS) significantly improves hypoglycemia alarms for type 1 diabetes mellitus (T1DM) patients. This sensor fusion enhances detection accuracy and predictive values, crucial for closed-loop glucose control.

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles
08:04

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles

Published on: November 3, 2023

Related Experiment Videos

Last Updated: Jun 16, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles
08:04

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles

Published on: November 3, 2023

Area of Science:

  • Biomedical Engineering
  • Endocrinology
  • Medical Device Technology

Background:

  • Continuous glucose monitoring systems (CGMS) are vital for type 1 diabetes mellitus (T1DM) management.
  • Enhanced hypoglycemia alarms are critical for improving the safety and acceptance of closed-loop glucose control systems.
  • Existing CGMS alarms can be augmented by integrating data from other physiological monitoring systems.

Purpose of the Study:

  • To perform an in silico analysis of a CGMS alarm system augmented with sensor fusion from a prototype autonomic nervous system (ANS) response feature alarm system (HypoMon).
  • To evaluate the impact of fusing ANS response features with CGMS data on hypoglycemia alarm performance in T1DM patients.
  • To assess the sensitivity, specificity, and predictive values of the enhanced alarm system compared to CGMS alone.

Main Methods:

  • Overnight blood glucose (BG) profiles from 98 T1DM volunteers were used for in silico modeling.
  • A probabilistic model simulated CGMS data and alarms, incorporating ANS response features detected by the HypoMon system.
  • Alarm algorithms were trained on 46 patients and validated on 56 patients, comparing CGMS-only versus fused data performance.

Main Results:

  • The addition of HypoMon data improved CGMS hypoglycemia alarm sensitivity from 87% to 97% while maintaining 85% specificity.
  • Positive predictive values increased from 61% to 66%, and negative predictive values improved from 96% to 99%.
  • Sensor fusion demonstrated stable performance enhancements, with potential for greater improvements at lower baseline CGMS alarm performance levels.

Conclusions:

  • Autonomic nervous system (ANS) response features offer complementary information that effectively enhances CGMS data for nocturnal hypoglycemia alarms.
  • Sensor fusion of ANS data with CGMS data significantly improves the accuracy and reliability of hypoglycemia detection in T1DM patients.
  • This approach holds promise for advancing the safety and efficacy of automated insulin delivery systems.